Circulating adiponectin concentrations are reduced in obese individuals, and this reduction
has been proposed to have a crucial role in the pathogenesis of atherosclerosis and …

Adiponectin is secreted by the adipose tissue and it has been shown to be down‐regulated
in states of insulin resistance and in cardiovascular disease. It has also been found to be …

One of the most common hepatic manifestations of the metabolic syndrome is non-alcoholic
fatty liver disease (NAFLD). This disease varies from simple steatosis to cirrhosis and …

Non-alcoholic fatty liver disease (NAFLD) is a common health problem with a high mortality
burden due to its liver-and vascular-specific complications. It is associated with obesity, high …

Adiponectin is secreted by the adipose tissue and is downregulated in states of obesity and
insulin resistance. There is a growing body of evidence indicating that adiponectin has …

Background Fibrates are widely used in the treatment of dyslipidemia and associated
metabolic abnormalities; however, their effects on adipokines are unclear. Aim of the study …

Studies have linked obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease
(CVD), nonalcoholic fatty liver disease (NAFLD) and dementia. Their relationship to the …

Purpose Adipokines produced by adipose tissue have been found to be involved in the
pathophysiology of metabolic and cardiovascular diseases. We aimed to investigate the …

Background Adiponectin, a peptide hormone secreted from adipocytes, exerts anti-diabetic,
anti-atherogenic, and anti-inflammatory properties. We aimed to determine the relationship …

With the aging population, dementia is becoming one of the most serious and troublesome
global public health issues. Numerous studies have been seeking for effective strategies to …